Related Experiment Videos
Serial changes in pulmonary functions in children hospitalized with cystic fibrosis
Insights
Inpatient treatment for cystic fibrosis (CF) improves pulmonary function, with vital capacity showing early gains. Continued improvement and maintenance of lung function were observed post-discharge.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Cystic Fibrosis Research
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting the lungs.
- Hospitalization is common for CF exacerbations requiring intensive treatment.
- Understanding treatment response is crucial for optimizing care.
Purpose of the Study:
- To quantify the timing and extent of pulmonary function improvement in children with CF during hospitalization.
- To assess the duration of these improvements after discharge.
- To compare treatment response based on initial disease severity.
Main Methods:
- Serial measurement of pulmonary functions (lung volumes, expiratory flows) every other day in 17 hospitalized children with CF.
- Standard inpatient care including chest physiotherapy, antibiotics, and bronchodilators.
- NIH scoring used to categorize disease severity at admission.
Main Results:
- Vital capacity improved by day 5, coinciding with reduced residual volume and increased peak expiratory flow.
- Significant improvements in other pulmonary functions occurred later during hospitalization.
- Improvements persisted throughout hospitalization and for 2 weeks post-discharge.
- Children with less severe initial lung disease (NIH score >50) showed greater and earlier improvement compared to those with severe disease (NIH score <50).
Conclusions:
- Inpatient treatment leads to measurable pulmonary function improvements in children with CF.
- Pulmonary function monitoring can guide decisions on optimal treatment duration.
- Disease severity at admission influences the rate and magnitude of treatment response.
Abstract:
Pulmonary functions were serially measured in 17 children hospitalized with cystic fibrosis (CF) to determine how much and when pulmonary functions improved during 14 days of inpatient treatment. Absolute lung volumes and forced expiratory flows were recorded every other day while patients received chest physiotherapy, antibiotics, and bronchodilators. Vital capacity first improved after the fifth hospital day coincidentally with a reduction in residual volume and an increase in peak expiratory flow rate. Significant improvements in other pulmonary functions developed later in the hospitalization. Improvement in most pulmonary functions continued throughout the hospitalization and was maintained 2 wk after discharge. Improvement was less and uniformly developed later in those children with severe lung disease on admission (NIH score less than 50) compared with those with moderate respiratory involvement (NIH score greater than 50). Pulmonary function measurements may prove useful in determining the optimal duration of treatment for patients who are hospitalized with CF.